Mark Johnson | Senior Director of IR |
Dr. Sanjay Shukla | President & CEO |
Dr. David King | Chief Scientific Officer |
Mathew Luchini | BMO |
Good day ladies and gentlemen and welcome to the aTyr Pharma Fourth Quarter 2017 Conference Call.
As a reminder to our audience, this conference is being recorded for replay purposes. It is now my pleasure to hand the conference over to Mark Johnson, Senior Director of Investor Relations. Sir you may begin.
Thank you, Gigi.